Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Lilly eyes more cancer deals, but wary of CAR-T, gene therapy

Eli Lilly and Co. remains in the hunt for cancer drugs even after announcing an $8 billion purchase of Loxo Oncology, but the company plans to remain on the sidelines when it comes to two of the hottest areas of drug development.

Read More »

Billions of Dollars This Week Show AI Is in BioPharma’s Present and Future

The tools of artificial intelligence continue to be essential elements for the biopharma industry. Companies across the sphere have invested heavily into the technology and this week, several more announced deals that bank on the use of artificial intelligence.

Read More »

AstraZeneca Lays off 210 in Colorado

AstraZeneca filed a Worker Readjustment and Retraining Notification Act (WARN) notice with the State of Colorado, indicating plans to lay off 210 people in Boulder and Longmont.

Read More »

Fund battling AIDS, TB and malaria seeks $14 billion to invigorate fight

At least $14 billion is needed to accelerate the fight against AIDS, tuberculosis and malaria and quell stubborn epidemics that still kill millions, the head of a global health fund said.

Read More »

Healthcare deals raise pulse of U.S. lending in 2019

Bankers are diagnosing another robust year for U.S. healthcare lending as the first two big loans of 2019 include the largest-ever tie-up in the pharmaceutical sector, and more are expected.

Read More »

AbelsonTaylor Launches ICONS.HEALTH

What do Microsoft, Aetna, Twitter, IBM, Ogilvy Consulting, Biogen and dozens of healthcare startups have in common? All appear in discussions about issues at the nexus of healthcare and technology in Icons.Health, a new video series produced by AbelsonTaylor.

Read More »

J&J raises U.S. prices on around two dozen drugs

Johnson & Johnson raised U.S. prices on around two dozen prescription drugs, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner Xarelto, all among the company’s top-selling products.

Read More »

Games industry asks WHO to hold fire on ‘gaming disorder’

Video games are compelling, but does playing them too much constitute a medical condition? The gaming industry is trying to avoid “gaming disorder” becoming a formally recognized ailment.

Read More »

Novartis Defends Itself Against Kickback Allegations from Former Employee

Swiss pharma giant Novartis has found itself at the center of a legal battle that could determine if the company engaged in a research project that was a kickback in disguise.

Read More »

Connecticut Judge Dismisses Opioid Drug Lawsuits

A judge dismissed lawsuits filed by 37 different municipal governments pertaining to opioid drugmakers being sued in the state of Connecticut.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!

Subscribe

Ad Right Bottom